[1] TU W J, ZHAO Z, YIN P, et al. Estimated Burden of Stroke in China in 2020 [J]. JAMA Netw Open, 2023, 6(3): e231455.
[2] DING Q, LIU S, YAO Y, et al. Global, Regional, and National Burden of Ischemic Stroke, 1990-2019 [J]. Neurology, 2022, 98(3): e279-e290.
[3] GHOSHAL S, FREEDMAN B I. Mechanisms of Stroke in Patients with Chronic Kidney Disease [J]. Am J Nephrol, 2019, 50(4): 229-239.
[4] AONO T, SHINYA Y, MIYAWAKI S, et al. Changes in the Risk of Stroke in Dialysis Patients: A Retrospective Analysis over the Last 40 Years [J]. Toxins (Basel), 2021, 13(5):
[5] DAWOD J, COULL B M. Chronic Kidney Disease is A Biomarker Rather Than A Risk Factor for Stroke [J]. J Stroke Cerebrovasc Dis, 2021, 30(9): 105869.
[6] SANDSMARK D K, MESSE S R, ZHANG X, et al. Proteinuria, but Not eGFR, Predicts Stroke Risk in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort Study [J]. Stroke, 2015, 46(8): 2075-2080.
[7] CHELLUBOINA B, VEMUGANTI R. Chronic kidney disease in the pathogenesis of acute ischemic stroke [J]. J Cereb Blood Flow Metab, 2019, 39(10): 1893-1905.
[8] NICKOLAS T L, KHATRI M, BODEN-ALBALA B, et al. The association between kidney disease and cardiovascular risk in a multiethnic cohort: findings from the Northern Manhattan Study (NOMAS) [J]. Stroke, 2008, 39(10): 2876-2879.
[9] THAMPY A, PAIS C C. Early Clinical Implications of Microalbuminuria in Patients with Acute Ischaemic Stroke [J]. J Clin Diagn Res, 2016, 10(9): OC29-OC31.
[10] JURKOVITZ C T, ABRAMSON J L, VACCARINO L V, et al. Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study [J]. J Am Soc Nephrol, 2003, 14(11): 2919-2925.
[11] TURANA Y, TENGKAWAN J, CHIA Y C, et al. Hypertension and stroke in Asia: A comprehensive review from HOPE Asia [J]. J Clin Hypertens (Greenwich), 2021, 23(3): 513-521.
[12] MAHMOODI B K, YATSUYA H, MATSUSHITA K, et al. Association of kidney disease measures with ischemic versus hemorrhagic strokes: pooled analyses of 4 prospective community-based cohorts [J]. Stroke, 2014, 45(7): 1925-1931.
[13] PARADA BARCIA J A, RAPOSEIRAS ROUBIN S, ABU-ASSI E, et al. Comparison of Stroke and Bleeding Risk Profile in Patients With Atrial Fibrillation and Chronic Kidney Disease [J]. Am J Cardiol, 2023, 196(31-37.
[14] TOYODA K, NINOMIYA T. Stroke and cerebrovascular diseases in patients with chronic kidney disease [J]. Lancet Neurol, 2014, 13(8): 823-833.
[15] KELLY D M, ROTHWELL P M. Does Chronic Kidney Disease Predict Stroke Risk Independent of Blood Pressure?: A Systematic Review and Meta-Regression [J]. Stroke, 2019, 50(11): 3085-3092.
[16] BAATEN C, SCHROER J R, FLOEGE J, et al. Platelet Abnormalities in CKD and Their Implications for Antiplatelet Therapy [J]. Clin J Am Soc Nephrol, 2022, 17(1): 155-170.
[17] MARINI S, GEORGAKIS M K, ANDERSON C D. Interactions Between Kidney Function and Cerebrovascular Disease: Vessel Pathology That Fires Together Wires Together [J]. Front Neurol, 2021, 12(785273.
[18] GEORGAKIS M K, CHATZOPOULOU D, TSIVGOULIS G, et al. Albuminuria and Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis [J]. J Am Geriatr Soc, 2018, 66(3): 509-517.
[19] TANG X, HAN Y P, CHAI Y H, et al. Association of kidney function and brain health: A systematic review and meta-analysis of cohort studies [J]. Ageing Res Rev, 2022, 82(101762.
[20] WEI C S, YAN C Y, YU X R, et al. Association Between White Matter Hyperintensities and Chronic Kidney Disease: A Systematic Review and Meta-Analysis [J]. Front Med (Lausanne), 2022, 9(770184.
[21] HOUGHTON D E, KOH I, ELLIS A, et al. Hemoglobin levels and coronary heart disease risk by age, race, and sex in the reasons for geographic and racial differences in stroke study (REGARDS) [J]. Am J Hematol, 2020, 95(3): 258-266.
[22] FAN F, YUAN Z, QIN X, et al. Optimal Systolic Blood Pressure Levels for Primary Prevention of Stroke in General Hypertensive Adults: Findings From the CSPPT (China Stroke Primary Prevention Trial) [J]. Hypertension, 2017, 69(4): 697-704.
[23] KOVESDY C P, ALRIFAI A, GOSMANOVA E O, et al. Age and Outcomes Associated with BP in Patients with Incident CKD [J]. Clin J Am Soc Nephrol, 2016, 11(5): 821-831.
[24] BRAGG F, HOLMES M V, IONA A, et al. Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China [J]. JAMA, 2017, 317(3): 280-289.
[25] LI R C, XU W D, LEI Y L, et al. The risk of stroke and associated risk factors in a health examination population: A cross-sectional study [J]. Medicine (Baltimore), 2019, 98(40): e17218.
[26] SPENCE J D, URQUHART B L. Cerebrovascular Disease, Cardiovascular Disease, and Chronic Kidney Disease: Interplays and Influences [J]. Curr Neurol Neurosci Rep, 2022, 22(11): 757-766.
[27] BOBOT M, THOMAS L, MOYON A, et al. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction [J]. J Am Soc Nephrol, 2020, 31(7): 1509-1521.
[28] LIU H, YE Y, CHEN Y, et al. Therapeutic targets for the anemia of predialysis chronic kidney disease: a meta-analysis of randomized, controlled trials [J]. J Investig Med, 2019, 67(6): 1002-1008.
[29] HUNG P H, YEH C C, HSIAO C Y, et al. Erythropoietin Use and the Risk of Stroke in Patients on Hemodialysis: A Retrospective Cohort Study in Taiwan [J]. J Am Heart Assoc, 2021, 10(14): e019529.
[30] MARTINEZ FERNANDEZ L, SANCHEZ-ALVAREZ J E, MORIS DE LA TASSA C, et al. Risk factors associated with valvular calcification in patients with chronic kidney disease. Analysis of NEFRONA study [J]. Nefrologia (Engl Ed), 2021, 41(3): 337-346.
[31] HUO Y, LI J, QIN X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial [J]. JAMA, 2015, 313(13): 1325-1335.
[32] XU X, QIN X, LI Y, et al. Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial [J]. JAMA Intern Med, 2016, 176(10): 1443-1450.
[33] POWER A. Stroke in dialysis and chronic kidney disease [J]. Blood Purif, 2013, 36(3-4): 179-183.
[34] FINDLAY M D, DAWSON J, MACISAAC R, et al. Inequality in Care and Differences in Outcome Following Stroke in People With ESRD [J]. Kidney Int Rep, 2018, 3(5): 1064-1076.
[35] SOZIO S M, ARMSTRONG P A, CORESH J, et al. Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study [J]. Am J Kidney Dis, 2009, 54(3): 468-477.
[36] MURRAY A M, SELIGER S, LAKSHMINARAYAN K, et al. Incidence of stroke before and after dialysis initiation in older patients [J]. J Am Soc Nephrol, 2013, 24(7): 1166-1173.
[37] MACEWEN C, SUTHERLAND S, DALY J, et al. Relationship between Hypotension and Cerebral Ischemia during Hemodialysis [J]. J Am Soc Nephrol, 2017, 28(8): 2511-2520.
